BioSilicium is a French biotechnology startup founded in 2015, specializing in expert systems, traceability, and quality software editing. The company's goal is to facilitate digital transformation at every stage and offer support through their expertise in three core areas. This includes Health, Quality, Hygiene, and Safety with their bs-QHSE software, Forensics with their bs-LIMS software, and Maintenance Management with their bs-CMMS software. These modules aim to ensure the digital transformation and management of various processes, such as QHSE processes, forensic laboratory processes, and machine fleet management and interventions. With its innovative software solutions, BioSilicium is positioned to address critical needs across multiple industries. The company's contact information is [email protected] and the website is https://biosilicium.fr. Currently, there is no available information on the last investment or the investors involved. BioSilicium presents an intriguing proposition for potential investors seeking opportunities in the biotechnology sector.
There is no investment information
No recent news or press coverage available for BioSilicium.